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Abstract
To reach the lymphatics, migrating dendritic cells (DCs) need to interact with the extracellular matrix (ECM). Heparanase,
a mammalian endo-b-D-glucuronidase, specifically degrades heparan sulfate proteoglycans ubiquitously associated with
the cell surface and ECM. The role of heparanase in the physiology of bone marrow-derived DCs was studied in mutant
heparanase knock-out (Hpse-KO) mice. Immature DCs from Hpse-KO mice exhibited a more mature phenotype; however
their transmigration was significantly delayed, but not completely abolished, most probably due to the observed
upregulation of MMP-14 and CCR7. Despite their mature phenotype, uptake of beads was comparable and uptake of
apoptotic cells was more efficient in DCs from Hpse-KO mice. Heparanase is an important enzyme for DC transmigration.
Together with CCR7 and its ligands, and probably MMP-14, heparanase controls DC trafficking.
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Introduction
Migrating dendritic cells (DCs) in different stages of maturation,
and after antigen uptake, enter the lymphatic circulation where
secondary lymphoid tissue chemokines (SLC/CCL21) and MIP-3-
b/CCL19,actingviaupregulatedCCR7,havecrucialroles[1,2,3,4].
However, to reach the lymphatics, migrating DCs need to interact
with, degrade, and transmigrate the extracellular matrix (ECM).
Upon transmigration, factors released from the degraded ECM [5]
may interact with DCsand influence their stimulatory capacity.
The ECM provides an essential physical barrier between cells
and tissues, as well as a scaffold for cell growth, migration,
differentiation, and survival. It undergoes continuous remodeling
during development and in a variety of pathological conditions,
including wound healing, inflammation, and cancer [6]. Heparan
sulfate side chains of heparan sulfate proteoglycans bind major
components of the ECM as well as multitude growth factors,
chemokines, and cytokines. Cleavage of heparan sulfate side
chains is therefore expected, not only to alter the structural
integrity of the ECM, but also to release and modulate the
activities of heparan sulfate-bound biological mediators [7].
Heparanase is an endo-b-D-glucuronidase capable of cleaving
heparan sulfate side chains at a limited number of sites [8,9,10].
Throughdegradationofheparansulfate,heparanasehasbeenshown
tofacilitateECMinvasionbymetastaticcancercells[11,12],aswellas
passage of immune cells such as macrophages [13], lymphocytes
[5,14,15], and DCs into their target tissues, as shown recently by us
[16]. Heparanase is synthesized by monocytes and early immature
DCsasapreformedlatentprotein.Itremainsactiveinimmature-and
matureDCs,anduponDCmaturationitaccumulatesinmembrane
extensions, mostlikely to allowECM degradation.
We generated heparanase-deficient (Hpse-KO) mice in order to
further study the role of heparanase in dendritic and other cells in
health and disease. The mice, which showed complete lack of
heparanase gene expression and enzymatic activity, developed
normally, as was recently shown [17]. The present study focuses
on examination of the role of heparanase in DCs from Hpse-KO
mice, with regard to phenotype, phagocytosis of apoptotic cells,
migration, and transmigration.
Results
To confirm complete disruption of the Hpse gene, expression of
heparanase mRNA derived from different tissues of wild-type
(WT) and Hpse-KO mice was examined by real-time PCR using
specific primers. The primers were designed to amplify the 59,
middle, and 39 regions of the heparanase gene. Heparanase
mRNA and enzymatic activity were detected in samples derived
from wt mice, but not in Hpse-KO mice [17].
Heparanase is Expressed in Bone Marrow-derived
Dendritic Cells from Hpse-WT but not Hpse-KO Mice
RNA from Hpse-WT and Hpse-KO mice was extracted and
heparanase gene expression was evaluated by RT-PCR. Figure 1A
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(BMDCs) from Hpse-WT mice vs. no expression of heparanase
RNA in BMDCs from Hpse-KO mice. We then sought to further
verify that lack of heparanase is associated with lack of enzymatic
activity [16]. Heparanase was active in immature BMDCs from
Hpse-WT mice but there was no activity in immature BMDCs
from Hpse-KO mice (Fig. 1B).
Comparable Yield and Morphological Appearance of DCs
from Hpse-WT and Hpse-KO Mice
Splenic dendritic cells had a comparable phenotype in both
Hpse-KO and Hpse-WT (Table 1). As shown, there was a clear
representation of all DC subpopulations. Mature DC number,
lymphoid cell number, and lymphoid DC number were decreased
in Hpse-KO mice, and plasmacytoid cell number was increased in
Hpse-KO mice [18], however, these tendencies did not reach
statistical significance.
We then compared the morphological appearance of BMDCs
derived from Hpse-KO vs. Hpse-WT. No significant differences
were observed using light and confocal microscopy (Figs. 2A and
2B). Flow cytometry analysis verified similar size and granularity
(Figs. 2C, 2D, and 2E). Likewise, the yields of iBMDCs and
mBMDCs from Hpse-WT and Hpse-KO mice were comparable
(Figs. 2C, 2D, and 2E) despite a slight tendency to higher yield in
the Hpse-KO.
Expression of Maturation and Migration Molecules is
Higher in DCs from Hpse-KO Mice
Dendritic cells were examined for expression of IA/IE and
costimulatory molecules (Fig. 3). CD80 was significantly elevated
in iBMDCs from Hpse-KO mice vs. Hpse-WT (Fig. 3A,
20.8564.24 versus 14.2863.29, p=0.05, t-test), and there was
a slight tendency toward increased CD86 and CD40 expression
that did not reach statistical significance. IA/IE was also
significantly increased in Hpse-KO mice (Fig. 3A, 63.15666.39
versus 31.92626.74, p=0.03, t-test). In addition, CCR7
showed, similarly to CD80 and IA/IE, higher expression in
Hpse-KO mice, although with borderline statistical significance
mainly due to a greater standard deviation (Fig. 3A, 1367.64
versus 5.3761.53, p=0.06, t-test). CD11c, as a control
molecule less related to maturation and migration, was
comparable in Hpse-KO and Hpse-WT mice (Fig. 3A). Upon
exposure to LPS as a maturation factor, there was a tendency
in most experiments for higher levels of CD80, IA/IE, and
CCR7 (Fig. 3B), that reached statistical significance just when
standardization was used taking Hpse-WT mice as 100%
(20.2967.18 versus 14.167.98, p=0.06; 70.58647.39 versus
44.35628.15, p=0.06; and 25.85617.87 versus 20.61619.09,
p=0.02, t-test, respectively). Using an additional maturation
factor, a cocktail of 30 ng/ml TNFa and 1 mg/ml PGE2, CD80
and CD86 levels in Hpse- WT mice reached levels comparable
to those in Hpse-KO mice. However, there was still a tendency
in most experiments for higher CCR7 and IA/IE in DCs from
Hpse-KO that did not reach statistical significant difference due
to a large standard deviation (Fig. 3C, 231.856250.6 versus
178.186227.36, p=0.08 for IA/IE, t-test). CD86 and CD40, in
Figure 1. Heparanase is not expressed and not active in BMDCs from Hpse-KO mice. A. Heparanase RT-PCR. RNA was extracted from
BMDCs of Hpse-WT and Hpse-KO mice. Primers specific for heparanase were used for RT-PCR (see Materials and Methods). Negative control represents
RT-PCR without primer of heparanase. L-19 is shown for comparison. B. Heparanase Enzymatic Activity. Heparanase activity was determined in lysates
of iBMDCs (closed circles) and mBMDCs (closed triangles) from Hpse-WT, and iBMDCs (opened circles) and mBMDCs (opened triangles) from Hpse-KO
mice. Low-molecular-weight labeled degradation fragments eluted toward the Vt of the column (peak II, fractions 15–30, 0.5,Kav,0.75) were
previously shown to be fragments of heparan sulfate. In contrast, sulfate-labeled material released from ECM by proteolytic enzymes or nondegraded
heparan sulfate is of much higher molecular weight, and eluted next to the void volume (peak I, fractions two-eight).The data shown are
representative of three experiments.
doi:10.1371/journal.pone.0035602.g001
Table 1. DC subpopulations in the spleen of wild type (Hpse-
WT) and heparanase-deficient mice (Hpse-KO).
Hpse-WT Hpse-KO P values
Dendritic cells (CD11c
+) 3.6460.33 3.1860.09 0.27
Mature DCs (CD11c
+ IA/IE
+) 3.2960.09 2.6760.001 0.07
Lymphoid DCs (CD11c
+ CD8a
+) 1.0560.24 0.7660.14 0.31
Myeloid DCs (CD11c
+ CD11b
+) 1.9060.14 1.5460.03 0.16
Plasmacytoid DCs (CD11c
+
B220
+)
0.6860.01 0.8760.23 0.46
The average and standard deviation of four spleens is shown.
doi:10.1371/journal.pone.0035602.t001
Role on Heparanase in Dendritic Cells
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PGE2, were less clearly increased (Figs. 3B and 3C).
Taken together, DCs in Hpse-KO mice showed a more mature
phenotype, both in the so-called immature state, and in response
to maturation signals. Interestingly, migration molecule CCR7
was highly expressed in both Hpse-KO iBMDCs and mBMDCs.
Apoptotic Cells are More Efficiently Phagocytosed by
iDCs from Hpse-KO Mice
We presumed that due to the mature phenotype seen in iDCs
from Hpse-KO mice, phagocytosis of apoptotic cells will be
decreased [19]. To our surprise, iDCs from Hpse-KO mice
Figure 2. Morphologic parameters of iBMDCs and mBMDCs are comparable in Hpse-WT and Hpse-KO mice. A. Wright staining of BMDCs
from Hpse-WT and Hpse-KO mice. B. Nomarsky view via confocal microscopy of BMDCs from Hpse-WT and Hpse-KO mice (zoom 6065, Olympus IX70,
Center Valley, PA). C. Representative dot plot analysis of side scatter (SSCH) and forward scatter (FSCH), and yield of iBMDCs. Average from five
experiments. D and E. The same for mBMDCs, matured with mTNFa + PGE2 (D), or LPS (E).
doi:10.1371/journal.pone.0035602.g002
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labeled beads were equally phagocytosed (Fig. 3D). Thus, despite
a ‘‘mature’’ phenotype, iDCs from Hpse-KO mice were highly
capable of apoptotic cell phagocytosis. Indeed, and not as
generally appreciated, LPS-matured DCs were reported to
maintain antigen capture via receptor-mediated endocytosis [20].
Cytokine Secretion from iDCs and mDCs is Comparable
in DCs from Hpse-WT and Hpse-KO Mice
We were interested to know whether, despite their more mature
phenotype, heparanase-deficient DCs are actually ‘‘semi-mature’’
DCs. Interestingly, E-cadherin-stimulated DCs failed to release
immunostimulatory cytokines, but exhibited a mature phenotype
with increased levels of MHC-class II and costimulatory molecules
[21]. These ‘‘mature’’ DCs were suggested to be ‘‘semi-mature’’
tolerizing DCs, as the expected cytokine profile was observed. In
contrast, as shown in Figure 4, DCs from Hpse-KO mice secreted
cytokines in a comparable way to those from Hpse-WT mice,
excluding the possibility of a ‘‘semi-mature’’ phenotype.
Figure 3. BMDCs from Hpse-KO mice have a phenotype with increased expression of maturation molecules and CCR7, and
phagocytose apoptotic cells more efficiently. A, B, and C. (A) iBMDCs and (B) mBMDCs matured with LPS, and (C) mBMDCs matured with
mTNFa + PGE2, from Hpse-WT and Hpse-KO mice, are stained for CD80, CD86, CD40, IA/IE, CCR7, and CD11c (black line), and for isotype control of
each marker (gray-filled curves). Mean fluorescence (MF) is the average of five experiments. Asterisk indicates p,0.02, t-test. D. Uptake of apoptotic
cells and FITC-labeled beads by iBMDC from Hpse-WT and Hpse-KO mice. Upper panel. Apoptotic cells were stained with DiI before the interaction
with iBMDCs. 2 hours after the interaction with apoptotic cells, iBMDCs were stained with CD11c.FITC. Mean fluorescence (MF) of double positive cells
is indicated. Phagocytosis was verified using confocal microscopy (not shown). Lower panel. As an additional control, FITC-labeled beads were offered
to CD11c. PE-stained iBMDCs (MF) of double positive cells are indicated.
doi:10.1371/journal.pone.0035602.g003
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Our previous study showed that heparanase plays an important
role in the transmigration of mature monocyte-derived DCs [16].
We were interested to study the transmigration of iBMDCs and
mBMDCs from Hpse-KO and Hpse-WT mice. We looked at
BMDC transmigration in an ECM-coated two-chamber model.
Figure 5A shows that iBMDC and mBMDC transmigration from
Hpse-KO mice was significantly inhibited (p,0.001) compared to
transmigration of iBMDCs and mBMDCs from Hpse-WT mice,
both in the presence and absence of 25 ng/ml and 50 ng/ml
MIP3b. Interestingly, despite a significantly lower transmigration
rate, CCR7 expression was significantly increased (p,0.001) in
both iBMDCs and mBMCs from Hpse-KO mice (Fig. 5A). Taken
together, transmigration was significantly impaired but partially
compensated, possibly due to upregulation of CCR7. We were
then interested to see whether this transmigration defect is seen in
vivo.
Heparanase is Needed for in vivo DC Transmigration
2610
6 mBMDCs from Hpse-KO and Hpse-WT mice were
stained with 2.5 mM CFSE and injected into the footpads of Hpse-
WT mice. After 24 and 48 hours, popliteal lymph nodes (2 per
mouse) were extracted, pooled, counted, and analysed by FACS
for the presence of cells that were double-positive for CD11c-PE
and CFSE.
CytoCount beads were used for evaluation of BMDC migration
rates. As can be seen in a representative experiment (one of three)
24 hours following the injection, on the gated DCs, 648 events of
CD11c+CFSE+ cells from Hpse-WT mice migrated to the
popliteal lymph nodes, compared to only 382 events of
CD11c+CFSE+ cells from Hpse-KO mice (Fig. 5B); thus a 28–
52% reduction in migratory DCs was seen in Hpse-KO
(p,0.0001). The total cell count in the popliteal lymph nodes
from mice that had been injected with mBMDCs from Hpse-WT
mice was 1.82610
6 cells, compared to the only slightly reduced
total cell count in popliteal lymph nodes from Hpse-KO mice that
were injected with PBS, which was 1.62610
6 cells. That suggests
the possibility that immune response and cell expansion are only
a slightly altered following DC migration. Interestingly, despite the
reduced number of mBMDCs from Hpse-KO mice that reached
the lymph nodes at 24 hours, almost the same number of cells,
1.6610
6, were counted in the nodes. To verify this observation,
lymph nodes were sampled 24 hours following injection, and
viewed using confocal microscopy. As shown in Figure 5D, fewer
CFSE-labeled DCs arrived in the T cell zones of the regional
popliteal lymph nodes.
On the other hand, 48 hours following the injection, on the
gated DCs, 397 events of CD11c+CFSE+ cells from Hpse-WT
mice were found in the popliteal lymph nodes, compared to 1017
events of CD11c+CFSE+ cells from Hpse-KO mice (Fig. 5B). In
conclusion, whereas a delay in the arrival of injected
Figure 4. Cytokine secretion from iDCs and mDCs is comparable in DCs from Hpse-WT and Hpse-KO mice. A, B, C and D. Following DC
maturation, supernatant culture was collected and analyzed by ELISA for (A) murine IL-12/IL-23(p40), (B) murine TNFa (C) murine IL-6, and (D) murine
IL-10 production. Asterisk indicates p,0.02, t-test.
doi:10.1371/journal.pone.0035602.g004
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accumulation and inhibition of natural decline in the number of
CD11c+CFSE+ cells was seen 48 hours following the injection.
In order to further verify that DC migration was not influenced
by the act of injecting the DCs into the footpads with possible
mechanical disruption of the basement membrane, we used an
additional transmigration assay in which a needle is not used:
mouse abdominal fur was shaved, and FITC was painted onto the
skin, as described elsewhere [22]. Tissue-resident DCs that pick up
the dye and migrate to the superficial inguinal nodes were counted
24 hours later. As shown in Figure 5C, similarly to the foot pad
transmigration assay, in Hpse-WT mice, 5.25% of lymph node cells
were CD11c+ DCs carrying FITC whereas only 3.53% (33%
inhibition, p,0.001) of CD11c+ DCs carrying FITC were found
in Hpse-KO mice.
MMP-14 is Overexpressed and MMP-9 is Downregulated
in DCs from Hpse-KO Mice
The unexpectedresult ofonly reduced migration, despite the fact
thatheparanaseisuniqueinitsabilitytodegradeheparansulfate,led
us to investigate whether other ECM degrading enzyme(s) were
compensating for the lack of heparanase expression. Taking into
accountthatmatrixmetalloproteinases(MMPs)playimportantrole
inrearrangingtheECMstructure,andtherebyintissueremodeling,
morphogenesis,andneovascularization, weinvestigatedtheexpres-
sion of MMPs by real-time PCR. For this purpose, total RNA
extracted from BMDC of Hpse-KO and WT mice was analyzed
using specific primers corresponding to MMP-2, -9,-25, and -14. As
shown in Figure 6, MMP-14 was overexpressed in mBMDCs from
Hpse-KO mice whereas MMP-9 was decreased in mBMDCs from
Hpse-KO mice.
Discussion
DCs are highly mobile cells with a superior capacity to recognize
and take up antigens to initiate an immune response. It has been
suggested that, in their immature stage of development, DCs patrol
in the periphery as sentinels to sample foreign- or self-antigens, and,
following specific pattern recognition receptors, undergo phenotyp-
ical and functional changes to differentiate into either their
Figure 5. Heparanase is needed for in vitro and in vivo transmigration. A. In vitro transmigration of iBMDCs or mBMDCs from Hpse-WT
(black bars) and Hpse-KO mice (gray bars). Cells were incubated in transwells coated with Matrigel (15 mg/50 ml DDW) 20–24 h at 37uC. Cells were
incubated with the lower chamber medium containing RPMI, RPMI with 25 ng/ml MIP3b or RPMI with 50 ng/ml MIP3b. Representative of three
experiments. Asterisk indicates p,0.02, t-test. B. In vivo DC transmigration. Flow cytometry. Dot plot of CD11c
+ and CFSE
+ cells from a popliteal
lymph node following foot pad injection of PBS, or, 2610
6 mBMDCs from Hpse-WT, or 2610
6 mBMDCs from Hpse-KO mice. mBMDCs were stained
with CFSE and injected SQ into the footpads of Hpse-WT mice. 24 hours or 48 hours after injection, the regional popliteal lymph node was extracted
and analyzed for the presence of CFSE+ cells by flow cytometry. CyoCount beads were used to evaluate cells that had migrated to the popliteal
lymph nodes. Representative of three experiments, (p,0.001). C. In vivo FITC skin painting. Dot plot of double positive CD11c-PE+ and FITC+ cells
from inguinal lymph nodes. The shaved abdomen was painted with FITC solution. 24 hours after the skin painting, the inguinal lymph node was
extracted and analyzed for the presence of CFSE+ cells by flow cytometry. D. Indirect immunofluorescence of frozen sections. Regional popliteal
lymph node frozen section of the same experiment in C. Confocal microscopy of lymph nodes stained as described in Methods. CFSE-migrating DCs
(green), CD11c migrating (yellow merged), local DCs (red), and T cells (blue), are seen.
doi:10.1371/journal.pone.0035602.g005
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migrate to the lymph nodes to present processed antigens to T cells
[23,24].TraffickingofbothimmatureandmatureDCsiscrucialfor
theexecutionoftheirfunctions,anddependsmainlyonchemotactic
attraction and ECM degradation-mediated migration. Chemotaxis
is critically modulated by chemokine responsiveness, mainly based
on CCR7 and its two ligands, CCL19 and CCL21 [25]. ECM
degradation in DC trafficking is poorly understood and was
suggestedtobeachievedprimarilybyheparanase[16],andpossibly
MMP-14 [26] or other undermined metallproteinases.
In this study, as anticipated from our previous research [16],
transmigration capacity in mBMDCs from Hpse-KO mice was
significantly reduced both in vitro and in vivo, most probably due
to the fact that ECM degradation is an important part of DC
transmigration. However, despite the unique role of heparanase,
transmigration was only reduced and not completely abolished.
This is most probably explained by the compensatory higher
expression of MMP-14 and CCR7 seen in BMDCs from Hpse-KO
mice. MMPs constitute a family of proteinases that participate in
cell migration [27]. MMPs may be expressed on the surface of
cells, thus allowing for precise, localized proteolysis that creates
a path for migrating cells [28]. Migration of both Langerhans cells
and dermal DCs was prevented by broad spectrum MMP
inhibitors (BB-3103), and by the natural tissue inhibitors of
metalloproteinases (TIMP), TIMP-1 and TIMP-2 [29]. In
addition, transmigration was rather delayed than inhibited as
seen by the numbers of DCs reaching the lymph node 48 hours
following the injection. At 48 hours following the injection it was
anticipated that the DC number will decline [30,31], as was seen
in the wild type. However, BMDCs from Hpse-KO mice were
found in higher numbers 48 hours following injection indicating
delayed arrival.
Different cells express different MMPs as compensation for
heparanase deficiency. Whereas DCs showed upregulation of
MMP-14 and downregulation of MMP-2 and MMP-9, other
tissues showed 2–3.5 fold overexpression of MMP-2 in many
samples extracted from Hpse-KO mice, but not in DCs. For
example, MMP-14 was overexpressed by 4–7 fold in the liver and
kidney, but was downregulated approximately 4 fold in mammary
glands derived from Hpse-KO mice. MMP-9 and MMP-25
expression levels were altered as well, depending on the tissue
[17]. MMP-9, reported to be important in DC migration [32,33],
was surprisingly downregulated in contrast to MMP-14 upregula-
tion, indicating perhaps different roles in transmigration. Upre-
gulation of MMP-14 is quite unique and specific, at least in DCs.
As a membrane-anchored protease on the cell surface, MMP-14 is
ideally positioned for efficient proteolysis of a wide variety of
substrates in the pericellular space. MMP-14 has been shown to
possess strong proteolytic activity, and is capable of degrading
ECM molecules, however, its role in modulating immune cell
migration is still poorly understood. So far it has been shown that
MMP-14 can directly modulate the migration of human
monocytes [34], and it has been suggested play a role in DC
degradation of the ECM [26].
Interestingly, cells transfected with active heparanase exhibited
a marked decrease in MMP-14 expression, as a mirror image of
the increased expression found in Hpse-KO mice. In contrast,
transfecting MDA-231 cells with mutant inactive heparanase did
not affect MMP expression [17], indicating that heparanase
enzymatic activity is involved in the observed regulation of MMP
expression. Taken together, this data may suggest that heparanase
and MMP-14 play synergistic and compensatory roles in DC
trafficking and may compensate for one another.
Another player is probably CCR7, which is a major molecule,
important for chemotaxis-based DC homing and migration to the
lymph nodes; in its absence, DCs exhibit impaired migration
[2,3,25,31,35]. Although it is not an ECM enzyme, CCR7 may
have, in a manner similar to MMP-14, a close relationship with
heparanase, as a molecule that compensates for the lack of
a heparan sulfate-degrading enzyme. These relationships between
a chemotactic migratory- and a transmigratory molecule are novel
and thus far unknown, and could indicate a close relationship
between two related functions.
DCs from Hpse-KO mice exhibited dissociation between an
increased mature phenotype and reduced transmigration capacity.
The phenotype represented true maturation, with capability of
pro-inflammatory cytokine secretion. It contrasted with the
deficiency in E-cadherin, where DCs exhibited the so-called
semi-mature phenotype, with increased MHC-class II and
costimulatory molecules, but without capability of pro-inflamma-
tory cytokine secretion [21].
It is not clear why costimulatory and IA/IE molecules are
upregulated in DCs from these mice, even in their immature state.
Is it the absence of heparanase, which may play an unknown
nuclear regulatory role [16], or could it be related to CCR7
upregulation? Indeed, CCL19, a CCR7 ligand, has been shown to
induce DC maturation, resulting in upregulation of costimulatory
molecules and the production of proinflammatory cytokines [36].
Interestingly, despite the mature phenotype, apoptotic cell uptake
was increased rather than decreased in DCs from Hpse-KO mice.
In summary, in vitro and in vivo transmigration is significantly
delayed in DCs from Hpse-KO mice, but not completely abolished,
most probably due to the observed upregulation of MMP-14 and
CCR7. Dissociation between increased maturation phenotype and
impaired transmigration is observed and may be related, at least in
part, to CCR7 expression. Heparanase is an important enzyme for
DC transmigration, and controls DC trafficking, together with
CCR7 and its ligands, probably MMP-14 and possibly additional
MMPs.
Figure 6. MMP expression. RT-PCR of MMPs in iBMDCs (black), and
mBMDCs (grilled black), from Hpse-WT or in iBMDCs (gray), mBMDCs
(grilled gray), from Hpse-KO mice. Maturation of BMDC was achieved
with a cocktail of 30 ng/ml recombinant mTNFa and 1 mg/ml PGE2 for
24 hrs. RNA was extracted from iBMDCs and mBMDCs from Hpse-WT
and Hpse-KO mice. Primers specific for MMP-2, MMP-9, MMP-25, and
MMP-14 were used for RT-PCR (see Methods). Asterisk indicates p,0.02,
t-test.
doi:10.1371/journal.pone.0035602.g006
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Reagents
Na2[
35S]O4 was purchased from GE Healthcare Bioscience
(Uppsala, Sweden). The bone marrow-derived DC medium
consisted of RPMI 1640 (Invitrogen-Gibco, Carlsbad, CA)
supplemented with 1% L-glutamine (Biological Industries, Kib-
butz Beit Haemek, Israel), 1% penicillin/streptomycin (Biological
Industries), 50 mM 2-mercaptoethanol (Sigma Aldrich, St Louis,
MO) and 10% heat-inactivated FBS (Biological Industries).
Recombinant murine granulocyte macrophage colony-stimulating
factor (GMCSF) was obtained from Peprotech/Tebu (Frankfurt,
Germany). Lipopolysaccharide (LPS), and mitomycin C, were
obtained from Sigma Aldrich.
Recombinant mouse tumor necrosis factor-alpha (TNFa) was
obtained from Prospect (Rehovot, Israel) and prostaglandin E2
(PGE2) from Cayman Chemical (Ann Arbor, MI). For the PCR
reaction mix, qPCR SYBR Master Mix was purchased from
Finnzymes (Espoo, Finland). For Western blot analysis, heparin-
agarose beads, a mixture of protease inhibitors, FITC and FITC-
labeled latex beads, and LPS were obtained from Sigma Aldrich,
and chemiluminescent substrate WestOne is was purchased from
iNtron Biotechnology (Gyeonggido, Korea). Matrigel for the
Matrigel transmigration assay was provided by Collaborative
Biomedical Products (Bedford, MA), recombinant mouse macro-
phage inflammatory protein-3 beta (mMIP-3b) was purchased
from R&D Systems (Minneapolis, MN), and CytoCount beads
were procured from Dako Cytomation (Glostrup, Denmark).
2.5 mM 5- and 6-carboxyfluorescein diacetate succinimidyl
(CFSE) was obtained from Invitrogen –Gibco (Carlsbad, CA)
Main fluorescein-conjugated Annexin V (Annexin V-FITC) and
propidium iodide (PI) were obtained from MBL, Inc. (Woburn,
MA). T cells were purified with the EasySep Kit, purchased from
StemCell Technologies (Vancouver, Canada).
Antibodies
Armenian hamster anti-mouse CD11c-PE, rat anti-mouse
CCR7-PE, Armenian hamster anti-mouse CD80-FITC, rat anti-
mouse CD86-FITC, Armenian hamster anti-mouse CD40-FITC,
rat anti-mouse I-A/I-E-FITC, and Armenian hamster anti-mouse
CD11c-FITC were purchased from BioLegend, Inc. (San Diego,
CA). Isotype controls, Armenian hamster IgG-FITC, FITC
Armenian hamster IgG-FITC, rat IgG2a, k-FITC, Armenian
hamster IgM-FITC, rat IgG2bk -FITC, rat IgG2b, and k-PE were
purchased from BioLegend, Inc. Isotype control rat IgG2a-PE was
obtained from Southern Biotech (Birmingham, AL). Goat anti-
mouse actin was purchased from Sigma Aldrich.
For indirect immunofluorescence (frozen section), purified
Armenian hamster anti-mouse CD11c, purified Armenian ham-
ster IgG isotype, biotin Armenian hamster anti-mouse CD3e and
biotin Armenian hamster IgG isotype control were purchased
from BioLegend, Inc. Goat anti-Armenian hamster Cy3 and
streptavidin Cy5 were purchased from Jackson ImmunoResearch
(West Grove, PA).
Mice
Wild-type mice (Hpse-WT) and heparanase-deficient mice (Hpse-
KO) were C57BL/6J background [17]. Mice were kindly provided
by Professor Israel Vlodavsky (Hebrew University, Jerusalem) and
the Bruce Rappaport Faculty of Medicine (Technion, Haifa,
Israel). BALB/c mice (Harlan, Jerusalem, Israel) were used for T
cell purification. All animal care protocols were approved by the
animal committees of the Hebrew University, Jerusalem, Israel
(MD-89.49-4) and the Biomedical Center, University of Uppsala,
Sweden (C176/2), according to NIH guidelines [17].
1,19-dioctadecyl-3,3,39,39-tetramethyl-indocarbocyanineper-
chlorate (DiI) was obtained from Molecular Probes.
Splenic DC Subpopulation
Spleens were excised and placed in ice cold PBS. Tissues were
mechanically minced with scissors. Cells were incubated for
3 min on ice and the supernatant was centrifuged at 1200 RPM,
4uC, 10 min to pellet. Hypotonic red blood cell lysis was
performed following wash in PBS. Spleen cells were resuspended
and stained with mouse-conjugated antibodies or isotype control
mouse for 30 min on ice, and washed.
Antibodies for mouse spleen DC subpopulations: Armenian
hamster anti-mouse CD11c-PE, rat anti-mouse CD45R/B220-
APC, rat anti-mouse IA/IE-FITC, rat anti-mouse CD11b-APC/
Cy7, and rat anti-mouse CD8a-PE/Cy7 were purchased from
BioLegend, Inc. Isotype controls, Armenian hamster IgG-PE, rat
IgG2a-APC, rat IgG2b-FITC, rat IgG2b-APC/Cy7, and rat
IgG1-PE/Cy7 were purchased from BioLegend, Inc.
Generation of Bone Marrow-derived DCs
BMDCs were generated according to the protocol of M.B.
Lutz [37], with mild modifications. Briefly, the femurs and tibiae
of female, 4–12 week old mice were removed and purified from
surrounding muscle tissue. Thereafter, intact bones were left for
disinfection in 70% ethanol for 1 min, washed twice in PBS, and
transferred into a fresh dish with RPMI 1640. Then both ends of
the bone were cut with scissors and the marrow was flushed with
2 ml of RPMI 1640 using a syringe and 25-gauge needle.
Clusters within the marrow suspension were disintegrated by
vigorous pipetting, and put on ice for 3 min to remove debris.
The cell culture medium was RPMI 1640-supplemented with
1% penicillin/streptomycin L-glutamine (2 mM), 2-mercap-
toethanol (50 mM), and 10% heat-inactivated FBS. At day 0,
BM leukocytes were seeded at 2610
6 cells per 100 mm dish in
10 ml cell culture medium containing 200 U/ml GMCSF. On
day 3, another 10 ml cell culture medium containing 200 U/ml
GMCSF was added to the plates. On days 6 and 8, half of the
culture supernatant was collected and centrifuged, and the cell
pellet was resuspended in 10 ml cell culture medium containing
200 U/ml GMCSF, and returned to the original plate.
Maturation of BMDC was achieved with 0.5 mg/ml LPS or
a cocktail of 30 ng/ml recombinant mTNFa and 1 mg/ml PGE2
for 24 hrs.
Preparation of Dishes Coated with ECM
Cultures of bovine corneal endothelial cells were established
from steer eyes and maintained in DMEM (1 g glucose/l)
supplemented with 5% newborn calf serum, 10% FCS, and
1 ng/ml bFGF [38]. Bovine corneal endothelial cells were plated
into 35 mm tissue culture dishes and cultured as described
above, except that 4% dextran T-40 was included in the growth
medium [7,38]. Na2
35SO4 (25 mCi/ml) was added on days 1 and
5 after seeding. On day 12, the subendothelial ECM was
exposed by dissolving the cell layer with PBS containing 0.5%
triton X-100 and 20 mM NH4OH, and washing four times with
PBS. The ECM remained intact, free of cellular debris, and
firmly attached to the entire area of the tissue culture dish [38].
Nearly 80% of ECM radioactivity was incorporated into heparan
sulfate glycosaminoglycans.
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To assess heparanase activity in whole cell lysates from Hpse-
WT and from Hpse-KO mice, 6610
6 cells were lysed by three
cycles of freezing and thawing, and incubated overnight at 37uC,
pH 5.8, on
35S-labeled ECM, prepared as described above, with
150 ml heparanase reaction solution (0.15 M NaCl, 20 mM
phosphate-citrate buffer, pH 5.8, 1 mM dithiothreitol [DTT],
and 1 mM CaCl2). The incubation medium was centrifuged and
the supernatant containing sulfate-labeled degradation fragments
was analyzed by gel filtration on a 0.9630 cm sepharose CL-6B
column (Sigma Aldrich). Fractions (0.2 ml) were eluted with PBS,
and their radioactivity was counted in a b-scintillation counter.
Degradation fragments of heparan sulfate side chains were eluted
from sepharose 6B at 0.5,Kav,0.8 (fractions 15–30, peak II).
Nearly intact heparan sulfate glycosaminoglycans were eluted at
Kav,0.2 (fractions 1–10, peak I) [7,39,40].
We used immobilized, sulfate-labeled ECM as a substrate, since
it resembles the natural substrate degraded by the cells in vivo
better than soluble heparin sulfate. Under this condition, de-
creased heparanase activity (i.e., a lower quantity of sulfate-labeled
material eluted in peak II, fractions 15–30, 4–10 kDa) is not
associated with an increase in the first peak (peak I), which
corresponds to nondegraded heparan sulfate (M.W..0.4610
6),
kDa, or proteolytic activity, not related to heparanase. This is
because the nondegraded, high molecular-weight material remains
bound to the dish, and hence is not subjected to gel filtration
analysis.
RNA and RT-PCR Isolation
RNA was isolated with the RNeasy Mini Handbook (Quiagen
GmbH, Hilden, Germany) according to the manufacturer’s
instructions, and was quantified by ultraviolet absorption. After
reverse transcription of 1 mg total RNA by oligo dT priming, the
resulting single strand cDNA was amplified using TaqDNA
polymerase (Promega, Madison, WI) and specific primers were
directed against human heparanase (4U: 59-ACA GTT CTA
ATG CTC AGT TGC TC-39 and 4L: 59-AAA GAC GGC TAA
GAT GCT GAA G-39). PCR conditions were initial denaturation
at 95uC for two minutes, denaturation at 96uC for 18 seconds,
annealing for 80 seconds at 58uC, and extension for 70 seconds at
72uC (33 cycles). Aliquots (10 ml) of the amplified cDNA were
separated by 1.5% agarose gel electrophoresis, visualized by
ethidium bromide staining, and compared to the expression level
of a ribosomal L-19 gene (L-19U: 59- ATG CCA ACT CTC GTC
AAC AG -39; L-19 L: 59- GCG CTT TCG TGC TTC CTT-39
[40,41]. Only RNA samples that gave completely negative results
in PCR without reverse transcriptase were further analyzed.
Flow Cytometry Analysis
Flow cytometry was performed on a FACScan
TM flow
cytometer (Becton Dickinson, Franklin Lakes, NJ), and data was
analyzed using FCS Express V3 analysis software (DeNovo
Software, Los Angeles, CA).
In vitro Matrigel Transmigration Assay
Transwell inserts (6.5 mm) fitted with polycarbonate filters
(5 mm pore, Corning Costar, High Wycombe, UK) were used.
The upper surface of the filter was coated with 15 mg of matrigel,
solubilized in 50 ml DDW, and air-dried for 1.5 hours in a hood.
The lower compartment was filled with 600 ml of RPMI 1640
medium, supplemented in some experiments with 25–50 ng/ml
recombinant mouse MIP-3b. BMDCs (50,000 cells/100 mlo f
RPMI) were then added to the upper compartment. The
chambers were incubated at 37uCi n5 %C O 2 for 24 hours.
Medium was collected from the lower compartment of the
chamber and CytoCount beads were added in some experiments.
An equal volume containing 20 ml of CytoCount beads, including
transmigrated BMDCs, was added by reverse pipetting to the
collected volume of the lower chambers in these experiments.
CytoCount beads are easily distinguished from cells in the plot of
side and forward scatter, and acquisition was stopped when 2,000
beads were counted. Results in these transmigration assays are
presented as the number relative to 2,000 beads and not as
a percent of input. Every experiment was performed in duplicate.
For confirmation, counting beads were used to obtain cell counts.
Since the beads had a high tendency to stick to the cells being
studied, an indirect approach was pursued. Before and after every
time point, a single tube with a known concentration of beads was
vortexed for 5 seconds and then acquired 3 times. The quantity of
beads corresponding to each sample tube was then calculated
using a simple linear equation based on the average bead values.
The quantity of cells gated was divided by the amount of beads in
the sample.
Flow cytometry was performed on a FACScan
TM, and data was
analyzed using FCS Express V3 analysis software (De Novo
Software, Los Angeles, CA).
In vivo Transmigration
Mature BMDCs (2610
6) were labeled with CFSE intracellular
fluorescent dyes for 5 minutes at room temperature. After labeling,
cells were washed extensively in PBS and injected subcutaneously
into the footpads of Hpse-WT mice. Increased DC migration was
elicited by subcutaneous pre-injection of 50 ng mTNFa into the
footpad 24 hours before footpad injection of the labeled mBMDCs
[31]. To analyze the number of migrating BMDCs, after 24 hours
popliteal lymph nodes were extracted and minced into small
fragments. Cells were analyzed for the presence of CD11c, PE,
and CFSE+ by flow cytometry. CytoCount beads were used to
evaluate cells that had migrated to the lymph nodes, as described
previously. Flow cytometry was performed on a FACScan
TM, and
data was analyzed using FCS Express V3 analysis software.
FITC Skin Painting (FITC Transmigration)
FITC (Sigma Aldrich) was dissolved (5 mg/ml) in a 50:50 (vol/
vol) acetone-dibutylphthalate mixture just before application.
0.2 ml of the FITC solution was painted on the shaved abdomens
of mice. Inguinal lymph nodes were obtained after 24 hours and
mechanically disaggregated [22]. Cells were analyzed for the
presence of CD11c-PE, and FITC
+ by flow cytometry. Flow
cytometry was performed on a FACScan
TM, and data was
analysed using FCS Express V3 analysis software.
Apoptotic Cell Interation with iDCs
Apoptotic cells were prepared as described elsewhere [42] and
stained with Dii according to the manufacturer’s instructions.
Labeled apoptotic cells were added to iDCs on day 6 of culture, for
1 or 2 h/37uC in 200 ml volume of culture media. In most assays,
iDCs were labeled with CD11c-FITC. Uptake was read by
a FACScan
TM. Uptake of FITC-latex beads (Sigma Aldrich), was
used as a control for phagocytosis by CD11c.PE+ DCs.
Cytokine Detection Assays
Cytokine production was assessed by analysis of culture
supernatants of BMDCs from Hpse-KO and Hpse-WT mice after
24 h maturation (day 9) or 48 h maturation (day 10) with 10 ng/
ml or 50 ng/ml or 100 ng/ml LPS, 10 mg/m or 5 mg/ml
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1 mg/ml PGE2. Supernatant was collected and kept at 220uC for
further analysis. ELISA kits from Diaclone Research (Besanc ¸on,
France) were used for the detection of murine IL-6, murine IL-10,
and murine TNFa. The ELISA Max Deluxe Set from BioLegend,
Inc. was used for the detection of mouse IL-12/IL-23 p40. ELISA
was performed according to the manufacturer’s instruction.
Recombinant cytokines were used as standards, with curves
generated from 15.6–500 pg/ml for murine IL-6, from 31.25–
1000 pg/ml for murine IL-10, and from 7.8–500 pg/ml for
TNFa, for mouse IL-12/IL-23 p40. Optical densities of the
samples and standards were measured using the Sunrise ELISA
Plate Reader (Tecan Group, Ma ¨nnedorf, Switzerland).
Matrix Metalloproteinase Analysis
Real-time quantitative PCR analysis was performed with an
automated rotor gene system RG-3000A (Corbett Research,
Sydney, Australia). The PCR reaction mix (20 ml) was composed
of 10 ml QPCR SYBR Master Mix and 5 ml of diluted cDNA
(each sample in a six-plicate), with a final concentration of 0.3 mM
of each primer. PCR conditions were as follows: an initial
denaturation step at 95uC for 15 minutes; 40 cycles of de-
naturation at 94uC for 15 seconds, hybridization at 57uC for 30
seconds, and elongation at 72uC for 30 seconds. The primers
MMP-2 (S: 59- AGC GTG AAG TTT GGA AGC AT-39 and AS:
59- CAC ATC CTT CAC CTG GTG TG-39), MMP-25 (S: 59-
GCT GAC TCG CTA TGG CTA CC-39 and AS: 59- GTC ATT
GGG TCC ATT TGT CC-39), MMP-14 (S: 59- GCC TGG AAC
ATT CTA ACG A-39 and AS: 59- CTT TGT GGG TGA CCC
TGA CT-39), and MMP-9 (S: 59-AGA CGA CAT AGA CGG
CAT CC-39 and AS: 59 GTG GTT CAG TTG TGG TGG TG-
39) were used. Actin primers (S: 59- ATG CTC CCC GGG CTG
TAT-39 and AS: 59- CAT AGG AGT CCT TCT GAC CCA
TTC-39) were used as an internal standard. The expression level of
different MMPs in the wt tissue was regarded as 100%, and the
MMP levels in the Hpse-KO mice were calculated relative to this
value.
Cell Staining, Tissue Histology, and Indirect
Immunofluorescence
BMDCs were placed on slides by cytospin (2 min, 1000 rpm)
and stained with Wright staining for light microscopy. Frozen
sections of popliteal lymph nodes were fixed in 4% para-
formaldehyde (10 min, room temperature) and stained with
purified Armenian hamster anti-mouse CD11c or purified
Armenian hamster IgG isotype control (1 h, room temperature),
and detected with goat anti- Armenian hamster Cy3 (30 min,
room temperature). Tissues were then stained with biotin
Armenian hamster anti-mouse CD3 or biotin Armenian hamster
IgG isotype control (1 hour, room temperature) and detected with
streptavidin Cy5 (30 minutes, room temperature). Sections were
viewed in confocal microscopy (zoom 6065, Olympus IX70,
Center Valley, PA).
Statistical Analysis
SigmaPlot software, version 10.0 (Systat Software, Chicago, IL)
was used to calculate statistical differences between groups, which
were compared using the paired Student’s t-test). All p values were
two-sided.
Author Contributions
Conceived and designed the experiments: SB DM. Performed the
experiments: SB IR EZ MA AG. Analyzed the data: SB IV DM. Wrote
the paper: SB IV DM.
References
1. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, et al. (1998) Selective
recruitment of immature and mature dendritic cells by distinct chemokines
expressed in different anatomic sites. J Exp Med 188: 373–386.
2. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, et al. (1999)
CCR7 coordinates the primary immune response by establishing functional
microenvironments in secondary lymphoid organs. Cell 99: 23–33.
3. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, et al. (1998) Rapid and
coordinated switch in chemokine receptor expression during dendritic cell
maturation. Eur J Immunol 28: 2760–2769.
4. Yanagihara S, Komura E, Nagafune J, Watarai H, Yamaguchi Y (1998) EBI1/
CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated
upon maturation. J Immunol 161: 3096–3102.
5. Vaday GG, Lider O (2000) Extracellular matrix moieties, cytokines, and
enzymes: dynamic effects on immune cell behavior and inflammation. J Leukoc
Biol 67: 149–159.
6. Timpl R (1996) Macromolecular organization of basement membranes. Curr
Opin Cell Biol 8: 618–624.
7. Vlodavsky I, Fuks Z, Bar-Ner M, Ariav Y, Schirrmacher V (1983) Lymphoma
cell-mediated degradation of sulfated proteoglycans in the subendothelial
extracellular matrix: relationship to tumor cell metastasis. Cancer Res 43:
2704–2711.
8. Freeman C, Parish CR (1998) Human platelet heparanase: purification,
characterization and catalytic activity. Biochem J 330 (Pt 3): 1341–1350.
9. Pikas DS, Li JP, Vlodavsky I, Lindahl U (1998) Substrate specificity of
heparanases from human hepatoma and platelets. J Biol Chem 273:
18770–18777.
10. Vlodavsky I, Friedmann Y (2001) Molecular properties and involvement of
heparanase in cancer metastasis and angiogenesis. J Clin Invest 108: 341–347.
11. Ilan N, Elkin M, Vlodavsky I (2006) Regulation, function and clinical
significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem
Cell Biol 38: 2018–2039.
12. Parish CR, Freeman C, Hulett MD (2001) Heparanase: a key enzyme involved
in cell invasion. Biochim Biophys Acta 1471: M99–108.
13. Sasaki N, Higashi N, Taka T, Nakajima M, Irimura T (2004) Cell surface
localization of heparanase on macrophages regulates degradation of extracel-
lular matrix heparan sulfate. J Immunol 172: 3830–3835.
14. Vlodavsky I, Mohsen M, Lider O, Svahn CM, Ekre HP, et al. (1994) Inhibition
of tumor metastasis by heparanase inhibiting species of heparin. Invasion
Metastasis 14: 290–302.
15. Fridman R, Lider O, Naparstek Y, Fuks Z, Vlodavsky I, et al. (1987) Soluble
antigen induces T lymphocytes to secrete an endoglycosidase that degrades the
heparan sulfate moiety of subendothelial extracellular matrix. J Cell Physiol 130:
85–92.
16. Benhamron S, Nechushtan H, Verbovetski I, Krispin A, Abboud-Jarrous G, et
al. (2006) Translocation of active heparanase to cell surface regulates
degradation of extracellular matrix heparan sulfate upon transmigration of
mature monocyte-derived dendritic cells. J Immunol 176: 6417–6424.
17. Zcharia E, Jia J, Zhang X, Baraz L, Lindahl U, et al. (2009) Newly generated
heparanase knock-out mice unravel co-regulation of heparanase and matrix
metalloproteinases. PLoS ONE 4: e5181.
18. Duriancik DM, Hoag KA (2009) The identification and enumeration of
dendritic cell populations from individual mouse spleen and Peyer’s patches
using flow cytometric analysis. Cytometry A 75: 951–959.
19. Verbovetski I, Bychkov H, Trahtemberg U, Shapira I, Hareuveni M, et al.
(2002) Opsonization of apoptotic cells by autologous iC3b facilitates clearance
by immature dendritic cells, down-regulates DR and CD86, and up-regulates
CC chemokine receptor 7. J Exp Med 196: 1553–1561.
20. Platt CD, Ma JK, Chalouni C, Ebersold M, Bou-Reslan H, et al. (4287–4292) .
21. Jiang A, Bloom O, Ono S, Cui W, Unternaehrer J, et al. (2007) Disruption of E-
cadherin-mediated adhesion induces a functionally distinct pathway of dendritic
cell maturation. Immunity 27: 610–624.
22. Cera MR, Del Prete A, Vecchi A, Corada M, Martin-Padura I, et al. (2004)
Increased DC trafficking to lymph nodes and contact hypersensitivity in
junctional adhesion molecule-A-deficient mice. J Clin Invest 114: 729–738.
23. Mevorach D (2003) Systemic lupus erythematosus and apoptosis: a question of
balance. Clin Rev Allergy Immunol 25: 49–60.
24. Steinman RM, Hawiger D, Nussenzweig MC (2003) Tolerogenic dendritic cells.
Annu Rev Immunol 21: 685–711.
25. Forster R, Davalos-Misslitz AC, Rot A (2008) CCR7 and its ligands: balancing
immunity and tolerance. Nat Rev Immunol 8: 362–371.
26. Yang MX, Qu X, Kong BH, Lam QL, Shao QQ, et al. (2006) Membrane type
1-matrix metalloproteinase is involved in the migration of human monocyte-
derived dendritic cells. Immunol Cell Biol 84: 557–562.
Role on Heparanase in Dendritic Cells
PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e3560227. Salmi M, Jalkanen S (2005) Cell-surface enzymes in control of leukocyte
trafficking. Nat Rev Immunol 5: 760–771.
28. Murphy G, Gavrilovic J (1999) Proteolysis and cell migration: creating a path?
Curr Opin Cell Biol 11: 614–621.
29. Ratzinger G, Stoitzner P, Ebner S, Lutz MB, Layton GT, et al. (2002) Matrix
metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells
and dermal dendritic cells from human and murine skin. J Immunol 168:
4361–4371.
30. Baumjohann D, Hess A, Budinsky L, Brune K, Schuler G, et al. (2006) In vivo
magnetic resonance imaging of dendritic cell migration into the draining lymph
nodes of mice. Eur J Immunol 36: 2544–2555.
31. MartIn-Fontecha A, Sebastiani S, Hopken UE, Uguccioni M, Lipp M, et al.
(2003) Regulation of dendritic cell migration to the draining lymph node: impact
on T lymphocyte traffic and priming. J Exp Med 198: 615–621.
32. Osman M, Tortorella M, Londei M, Quaratino S (2002) Expression of matrix
metalloproteinases and tissue inhibitors of metalloproteinases define the
migratory characteristics of human monocyte-derived dendritic cells. Immunol-
ogy 105: 73–82.
33. Yen JH, Khayrullina T, Ganea D (2008) PGE2-induced metalloproteinase-9 is
essential for dendritic cell migration. Blood 111: 260–270.
34. Matias-Roman S, Galvez BG, Genis L, Yanez-Mo M, de la Rosa G, et al. (2005)
Membrane type 1-matrix metalloproteinase is involved in migration of human
monocytes and is regulated through their interaction with fibronectin or
endothelium. Blood 105: 3956–3964.
35. D’Amico G, Bianchi G, Bernasconi S, Bersani L, Piemonti L, et al. (1998)
Adhesion, transendothelial migration, and reverse transmigration of in vitro
cultured dendritic cells. Blood 92: 207–214.
36. Marsland BJ, Battig P, Bauer M, Ruedl C, Lassing U, et al. (2005) CCL19 and
CCL21 induce a potent proinflammatory differentiation program in licensed
dendritic cells. Immunity 22: 493–505.
37. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, et al. (1999) An
advanced culture method for generating large quantities of highly pure dendritic
cells from mouse bone marrow. J Immunol Methods 223: 77–92.
38. Vlodavsky I (1999) Preparation of extracellular matrices produced by cultured
corneal endothelial and PF-HR9 endodermal cells. Curr Protocols Cell Biol
Suppl 1 Unit 10–14.
39. Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, et al. (1999)
Cloning of mammalian heparanase, an important enzyme in tumor invasion and
metastasis. Nat Med 5: 803–809.
40. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, et al. (1999)
Mammalian heparanase: gene cloning, expression and function in tumor
progression and metastasis. Nat Med 5: 793–802.
41. Goldshmidt O, Zcharia E, Abramovitch R, Metzger S, Aingorn H, et al. (2002)
Cell surface expression and secretion of heparanase markedly promote tumor
angiogenesis and metastasis. Proc Natl Acad Sci U S A 99: 10031–10036.
42. Ablin J, Verbovetski I, Trahtemberg U, Metzger S, Mevorach D (2005)
Quinidine and procainamide inhibit murine macrophage uptake of apoptotic
and necrotic cells: a novel contributing mechanism of drug-induced-lupus.
Apoptosis 10: 1009–1018.
Role on Heparanase in Dendritic Cells
PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e35602